WALLINGFORD: Bristol-Myers Squibb Company has changed direction and will no longer relocate 500 employees to a new location in Connecticut. BMS announced previously its intention to close its 1 million square feet Wallingford research center and to relocate the 500
employees elsewhere in Connecticut.
The change in plans is part of a wider move to consolidate operations in Hopewell, New Jersey and Seattle, Washington.
BMS will distribute those jobs across other facilities and is adding to its Lawrenceville, New Jersey campus and expand its Devens, Massachusetts facility. None of the jobs will remain in Connecticut.